Good morning and welcome to Novavax' Third Quarter 2024 Financial Results and Operational Highlights Conference Call. All ...

GSK remains on fairly stable financial footing, with a debt/EBITDA ratio of 2.1 at the end of 2023 and Haleon taking on close to GBP 10 billion of GSK's debt in the 2022 divestment. With the improving ...

Novavax, Inc. ( NASDAQ: NVAX) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET ...

“Sponsors have the option to offer enhanced or alternative plans that use a structure of cost ... for diabetes patients. Free vaccines, including the shingles vaccine and the combined tetanus ...

“QS-21 today is present in a blockbuster vaccine, probably the most important vaccine in the pre-COVID era, which is this shingles vaccine ... although the cost structure will behave more ...

Italy is getting older. With a sobering demographic curve and new economic challenges to keep under control. It is on ...

The new book edited by Naomi Wolf with Amy Kelly is now selling like hotcakes – and for good reason. The Pfizer Papers: ...

“This is usual for us,” said Brianne Spaeth, PharmD., owner and pharmacist for the SaddleBrooke business. “It’s like ‘Cheers, ...

Skipping Annual Vaccinations Staying up to date with vaccinations, including the flu vaccine, shingles vaccine ... While a basic routine can provide structure and security, too much predictability can ...

SEATTLE, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Curevo Vaccine (Curevo), a privately-held clinical-stage biotechnology company dedicated to developing varicella zoster virus (VZV) vaccines with ...

Zero shingles cases after 18.8 months follow-up in 619 patients receiving any dose of amezosvatein, a development-stage adjuvanted subunit vaccine -- Ten shingles cases would have been expected absent ...